92.25
前日終値:
$90.58
開ける:
$90.705
24時間の取引高:
14.51M
Relative Volume:
1.11
時価総額:
$251.88B
収益:
$64.17B
当期純損益:
$17.12B
株価収益率:
13.71
EPS:
6.73
ネットキャッシュフロー:
$18.10B
1週間 パフォーマンス:
+3.07%
1か月 パフォーマンス:
-6.65%
6か月 パフォーマンス:
-22.12%
1年 パフォーマンス:
-27.45%
Merck Co Inc Stock (MRK) Company Profile
MRK を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MRK
Merck Co Inc
|
92.25 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
![]()
LLY
Lilly Eli Co
|
920.63 | 874.97B | 45.04B | 10.59B | 414.30M | 11.71 |
![]()
NVO
Novo Nordisk Adr
|
90.65 | 402.40B | 42.09B | 14.65B | 10.11B | 3.2833 |
![]()
ABBV
Abbvie Inc
|
209.03 | 369.01B | 56.33B | 4.28B | 17.83B | 2.40 |
![]()
JNJ
Johnson Johnson
|
165.02 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-18 | ダウングレード | Deutsche Bank | Buy → Hold |
2025-02-10 | ダウングレード | TD Cowen | Buy → Hold |
2025-01-08 | ダウングレード | Truist | Buy → Hold |
2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-12-10 | 再開されました | BofA Securities | Buy |
2024-12-04 | アップグレード | HSBC Securities | Hold → Buy |
2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
2024-11-11 | ダウングレード | Daiwa Securities | Buy → Neutral |
2024-10-17 | 開始されました | Bernstein | Mkt Perform |
2024-03-11 | ダウングレード | Societe Generale | Hold → Sell |
2024-01-04 | アップグレード | TD Cowen | Market Perform → Outperform |
2023-11-09 | 開始されました | Deutsche Bank | Buy |
2023-10-27 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2023-10-20 | アップグレード | UBS | Neutral → Buy |
2023-07-14 | 開始されました | HSBC Securities | Hold |
2023-04-13 | アップグレード | Citigroup | Neutral → Buy |
2023-03-28 | ダウングレード | Societe Generale | Buy → Hold |
2023-03-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2023-03-06 | 開始されました | Jefferies | Buy |
2023-02-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2023-01-04 | アップグレード | BofA Securities | Neutral → Buy |
2022-11-18 | 開始されました | Credit Suisse | Outperform |
2022-10-10 | アップグレード | Guggenheim | Neutral → Buy |
2022-09-14 | アップグレード | Berenberg | Hold → Buy |
2022-07-06 | アップグレード | Daiwa Securities | Neutral → Buy |
2022-06-06 | 再開されました | SVB Leerink | Outperform |
2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
2021-12-17 | 開始されました | Goldman | Buy |
2021-12-16 | 開始されました | Daiwa Securities | Neutral |
2021-12-13 | ダウングレード | UBS | Buy → Neutral |
2021-12-09 | 開始されました | Wells Fargo | Overweight |
2021-12-07 | ダウングレード | Guggenheim | Buy → Neutral |
2021-11-29 | ダウングレード | Citigroup | Buy → Neutral |
2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
2021-11-01 | アップグレード | Argus | Hold → Buy |
2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-07-27 | 再開されました | Truist | Buy |
2021-05-20 | ダウングレード | Argus | Buy → Hold |
2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
2020-11-10 | 再開されました | Bernstein | Outperform |
2020-09-29 | 開始されました | Berenberg | Hold |
2020-08-03 | アップグレード | Goldman | Neutral → Buy |
2020-06-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2020-02-27 | 開始されました | Barclays | Overweight |
2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
2019-10-17 | 再開されました | BofA/Merrill | Neutral |
2019-08-16 | 開始されました | SVB Leerink | Outperform |
2019-07-03 | 開始されました | Mizuho | Buy |
2019-05-28 | 開始されました | Goldman | Neutral |
2019-05-13 | アップグレード | Atlantic Equities | Neutral → Overweight |
2018-10-16 | 繰り返されました | Citigroup | Buy |
2018-10-09 | 再開されました | Guggenheim | Buy |
2018-04-23 | アップグレード | Goldman | Neutral → Buy |
2018-04-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2018-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
2018-03-12 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
2018-02-14 | 繰り返されました | Leerink Partners | Mkt Perform |
2018-02-07 | 繰り返されました | Morgan Stanley | Equal-Weight |
2018-01-16 | アップグレード | SunTrust | Hold → Buy |
すべてを表示
Merck Co Inc (MRK) 最新ニュース
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck LawsuitMRK - PR Newswire
Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds - Insider Monkey
MRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before - The Bakersfield Californian
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK - GlobeNewswire Inc.
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Middleton & Co. Inc. MA - MarketBeat
Nichols & Pratt Advisers LLP MA Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Metis Global Partners LLC - MarketBeat
Poplar Forest Capital LLC Lowers Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by US Bancorp DE - MarketBeat
Fisher Asset Management LLC Grows Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Bank OZK Acquires 2,981 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mutual of America Capital Management LLC Sells 13,866 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Dynasty Wealth Management LLC Invests $480,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Nelson Capital Management LLC Sells 30,402 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Up 0.6%Here's What Happened - MarketBeat
Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025? - Insider Monkey
Berenberg Adjusts Price Target on Merck to $115 From $125, Maintains Buy Rating - Marketscreener.com
Q2 EPS Estimate for Merck & Co., Inc. Reduced by Analyst - MarketBeat
Illumine Investment Management LLC Acquires Shares of 2,940 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Motco Boosts Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Altrius Capital Management Inc Purchases 6,378 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Argyle Capital Management LLC Has $5.78 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by CORDA Investment Management LLC. - MarketBeat
Proficio Capital Partners LLC Has $107 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Denali Advisors LLC Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Holdings Raised by NewEdge Wealth LLC - MarketBeat
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Merck & Co., Inc. (NYSE:MRK) Trading Up 1.2%Still a Buy? - MarketBeat
Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; ... - The Bakersfield Californian
Merck & Co., Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Decoding Merck & Co's Options Activity: What's the Big Picture? - Benzinga
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - The Malaysian Reserve
Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
QRG Capital Management Inc. Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Alphinity Investment Management Pty Ltd - MarketBeat
Motiv8 Investments LLC Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co - MarketBeat
Alecta Tjanstepension Omsesidigt Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mn Services Vermogensbeheer B.V. Grows Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kovack Advisors Inc. Sells 8,570 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Oppenheimer & Co. Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Q1 EPS Forecast for Merck & Co., Inc. Reduced by Analyst - MarketBeat
Schnieders Capital Management LLC Has $1.60 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
SRN Advisors LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Lessened by Lineweaver Wealth Advisors LLC - MarketBeat
Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Merck Co Inc (MRK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):